Xela Domains Logo

TYPE1RX.COM

WELCOME TO TYPE1RX.COM

TYPE1RX.COM is type-1 diabetes pharmacy English: Type 1 Rx—insulin and type-1 counseling hubs that already need Type 1 (not Type 2) with Rx—sibling to Type2Rx but autoimmune/insulin-first voice. Disease-type lockup; buyer owns clinical claims.

Best-fit buyers: diabetes education publishers; specialty insulin desks; device/CGM adjacent media; defensive holders. Exact-fit launch: a Type 1 Rx hub with insulin FAQ, device tiles, and support CTA.

CDC NCHS reports 15.8% of U.S. adults had total diabetes during August 2021–August 2023 (11.3% diagnosed; 4.5% undiagnosed)—the prevalence spine Type 1 counseling still sits inside.[1] ASHP put U.S. prescription drug spending at $915.2 billion in 2025—the national Rx spend insulin and device education rides.[2] That diabetes × Rx spine frames why exact Type 1 Rx inventory matters—not an invented category TAM.

Why Choose TYPE1RX.COM

BUY NOW - $33,722

Buy Now — TYPE1RX.COM. Own the Type 1 Rx pharmacy hostname.

MAKE AN OFFER

Purchase TYPE1RX.COM today through our trusted partners:

WHAT DOES ALLISON IVES THINK?

Allison Ives

"Type1Rx.com is type-1 inventory—insulin counseling English, not a Type2Rx twin."

Allison Ives, Contracts Specialist
Contact Allison Ives via Email

FAQs

Who buys Type1Rx.com?

Diabetes education publishers, specialty insulin desks, device/CGM media, and defensive holders.

What figures are cited?

CDC: 15.8% adults with diabetes; ASHP: $915.2B Rx (2025).

Vs Type2Rx.com?

Type 1 vs Type 2 disease-type pharmacy—unique siblings.

Is this medical advice?

No—brandable naming; buyer owns clinical content.

Contact Us

We're here to help you secure TYPE1RX.COM. Reach out today and claim this premium brandable. 📬

📧 Email: info@xeladomains.com
📞 Phone: (858) 429-9352

Social Networks

Follow us on Instagram and connect with us on LinkedIn for updates and more information.

Instagram | LinkedIn

REFERENCES

  1. CDC NCHS Data Brief 516 — 15.8% of U.S. adults had total diabetes (11.3% diagnosed; 4.5% undiagnosed), Aug 2021–Aug 2023
  2. ASHP — U.S. prescription drug spending $915.2B in 2025 (+12.7%); trajectory >$1T in 2026